Welcome to our dedicated page for Centene Del news (Ticker: CNC), a resource for investors and traders seeking the latest updates and insights on Centene Del stock.
Centene Corporation (NYSE: CNC) generates a steady flow of news related to government-sponsored healthcare programs, local health plans, and community health initiatives. As a Fortune 500 healthcare enterprise, Centene and its subsidiaries regularly issue updates on Medicaid and Medicare activities, Marketplace products, investor communications, and efforts to address social drivers of health such as food insecurity.
News items for Centene often feature announcements from local health plans that are companies of Centene Corporation. Examples include Health Net in California, Meridian Health Plan of Illinois, Ambetter Health Marketplace offerings, Coordinated Care in Washington, and specialty pharmacy activities from AcariaHealth. These stories cover topics such as value-based care partnerships, emergency assistance for members during natural disasters, public service announcements promoting preventive care, and investments in food banks and mobile pantry programs.
Investors and analysts following CNC can also find coverage of earnings-related events and financial communications. Centene files Form 8-K reports on quarterly results, updates to financial guidance, participation in healthcare conferences, and changes in board composition. These disclosures provide insight into the company’s financial outlook, use of non-GAAP measures, and governance developments.
For stakeholders interested in public health and community impact, Centene-related news highlights grants and collaborations with food banks, community organizations, and nutrition programs across multiple states. These initiatives illustrate how the enterprise and the Centene Foundation seek to improve access to nutritious food and support whole-person health. This news page brings together such corporate, financial, and community-focused updates for Centene Corporation and its affiliated health plans.
Summary not available.
Centene Corporation (NYSE: CNC) has updated its 2022 guidance, increasing Premium and Service Revenues by $2.0 billion to a range of $134.3 billion to $136.3 billion and Adjusted Diluted EPS guidance to $5.55 to $5.70. The company plans to reduce its real estate footprint, anticipating one-time costs of $1.5 to $1.65 billion but expects to cut annualized leased real estate expenses by $180 million to $200 million. Additionally, the Board has authorized a $3 billion increase to its stock repurchase program and a $1 billion debt repurchase program.
Health Net, a leading Medi-Cal partner in California, has announced a collaboration with MedArrive to provide in-home COVID-19 vaccinations for vulnerable members and their families. This initiative targets areas like Los Angeles, Sacramento, and Fresno, facilitating access for those facing social and economic barriers. Eligible members can schedule home visits with licensed healthcare professionals. The program is part of Health Net's broader efforts to enhance health equity and increase vaccination rates among underserved populations in California.
Centene Corporation (NYSE: CNC) will hold a virtual Investor Meeting on June 17, 2022. The meeting will feature insights from senior management and will be live-streamed on the Centene website under the Investors section. Centene, a Fortune 25 healthcare leader, focuses on providing high-quality and cost-effective services to under-insured and uninsured individuals. The company serves nearly 1 in 15 people in the U.S. and operates in international markets, ensuring long-term growth and value creation for its members and community.
Health Net has released a report titled Innovating Within Medi-Cal, outlining strategies to improve healthcare access and reduce disparities for vulnerable Californians. The report emphasizes leveraging data to identify at-risk populations and implementing simple solutions to enhance patient engagement. Health Net has invested over $100 million since 2017 in community initiatives. Key recommendations include investing in data infrastructure and designing interventions that minimize complexity, aiming to close health outcome gaps.
The Behavioral Health Center of Excellence (BHCOE) has teamed up with Centene Corporation (NYSE:CNC) to enhance Applied Behavioral Analysis (ABA) treatment delivery, targeting improved access for individuals with autism and related developmental disabilities. This partnership leverages BHCOE's expertise in quality measurement with Centene's commitment to integrated healthcare services. With a reported 18% rise in autism diagnoses among children from 2016 to 2018, this collaboration aims to establish national healthcare quality standards for behavioral health and improve ABA services within a value-based care framework.
Centene Corporation (NYSE: CNC) announced that its Missouri subsidiary, Home State Health, has secured the MO HealthNet Managed Care General Plan and Specialty Plan. This contract allows Home State to serve various Medicaid programs, including 40,000 foster children. The plan aims to provide trauma-informed healthcare services for children in custody. This one-year contract also includes options for four renewals. Currently, Home State Health supports over 300,000 Medicaid enrollees and partners with 25,000 healthcare providers in Missouri.
Investor consortium led by Nautic Partners, The Vistria Group, and General Atlantic has reached a definitive agreement to acquire PANTHERx Rare from Centene Corporation (NYSE: CNC). This strategic move aims to accelerate PANTHERx's growth as a specialty pharmacy for rare and orphan diseases. With a focus on meeting the unique needs of patients, the consortium anticipates leveraging expertise to drive innovation. The transaction awaits clearance under the Hart-Scott Rodino Act and other customary conditions. PANTHERx is recognized for its achievements in the specialty pharmacy sector.
Centene Corporation (NYSE: CNC) announced the sale of two pharmacy businesses, Magellan Rx and PANTHERx, to Prime Therapeutics and a consortium respectively, generating approximately $2.8 billion in proceeds. This move aligns with Centene's strategy to exit the Pharmacy Benefit Management space, enhancing value creation. Magellan Rx, acquired in January 2022, is known for specialty drug management, while PANTHERx, acquired in December 2020, excels in rare pharmacy. The transactions are expected to be neutral to slightly accretive to Centene’s Adjusted Earnings Per Share post-closing.
Centene Corporation (NYSE: CNC) will present at the Bank of America 2022 Healthcare Conference in Las Vegas from May 9-13, 2022. The company's presentation is scheduled for May 10 at 8:40 a.m. PT, with a live audio webcast available at this link. A replay will be accessible on Centene's website under the Investors section afterwards. Centene is a leading healthcare enterprise focused on providing integrated, cost-effective services, particularly for under-insured and uninsured individuals.